ACN Newswire

Tue Jan 7

Eisai's Fycompa for Adjunctive Treatment of Partial Onset Seizures Launched in China

Written by ACN Newswire

TOKYO, Jan 6, 2020 - (JCN Newswire) - Eisai Co., Ltd. has launched the in-house discovered and developed antiepileptic drug (AED) Fycompa, (generic name perampanel) for use in the adjunctive treatment of partial-onset seizures (with or without secondarily generalized seizures) in epilepsy patients 12 years of age and older.In China, it is...

Read more: Eisai's Fycompa for Adjunctive Treatment of Partial Onset Seizures Launched in China

ACN Newswire

Eisai's Fycompa for Adjunctive Treatment of Partial Onset Seizures Launched in China

Hurricane Dorian: where it hit, where it's headed, and why it's so destructive

Why Australia's first securities class action judgment (sort of) cleared Myer

Aboriginal people lived in Australia's desert interior 50,000 years ago, earlier than first thought

With apartment living on the rise, how do families and their noisy children fit in?

If we want students to feel safe at school, we can't encourage teachers to spot potential extremists

Did Al Jazeera's undercover investigation into One Nation overstep the mark?

Top 10 Promotional Products for Small Businesses

Meet the Kakadu plum: an international superfood thousands of years in the making

Religious groups are embracing technology during the lockdown, but can it replace human connection?

What parents need to know about the signs of child sexual abuse

Revised DrinkWise posters use clumsy language to dampen alcohol warnings